How big is the Plasmid DNA Market | Biotechnology & Gene Therapy Forecast 2026

How big is the plasmid DNA market?

The market growth is driven by increasing applications of plasmid DNA in gene therapy, DNA vaccines, and cell & gene therapy research, coupled with rising R&D investments in biotechnology.

Key Growth Drivers of the Plasmid DNA Market

• Increasing applications of plasmid DNA in cell and gene therapy
• Increasing interest in the preventive measures with DNA vaccines against infectious diseases
• Increased investment in genetic and molecular biology research
• There is a growing use of high-end biomanufacturing technology
• Favourable regulatory supports on the usage of DNA based therapies

Plasmid DNA Market Trends

The plasmid DNA market is experiencing trends such as surging clinical trials for DNA-based therapeutics, growing commercialization of DNA vaccines, and technological improvements in plasmid purification and scalable manufacturing. There is rising interest in synthetic biology and CRISPR applications that rely heavily on plasmid DNA constructs. Contract development and manufacturing organizations (CDMOs) are increasingly offering plasmid DNA services, enhancing global production capacity.

Emerging Developments in the Plasmid DNA Market

The plasmid DNA market is undergoing developments like large-scale facility expansions, adoption of high-yield production systems, and strategic collaborations between biotech firms and CDMOs. Companies are focusing on reducing production costs, improving regulatory compliance, and strengthening supply chains to meet the rising global demand. The launch of GMP-compliant plasmid DNA products is reshaping the competitive landscape.

List of Leading Companies in the Plasmid DNA Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Aldevron (a Danaher Company)

Aldevron is a leading provider of custom plasmid DNA, proteins, and mRNA, supporting gene therapy, vaccine, and cell therapy developers worldwide.

2. VGXI, Inc.

VGXI specializes in cGMP-grade plasmid DNA manufacturing, serving DNA vaccines, gene therapy, and applications from preclinical to commercial scale.

3. Kaneka Eurogentec S.A. (Kaneka Corporation)

Eurogentec provides large-scale GMP plasmid DNA manufacturing, supporting vaccines, gene therapy, and cell therapy product development.

4. Thermo Fisher Scientific Inc.

Thermo Fisher offers plasmid DNA tools, kits, and services, enabling molecular biology, clinical research, and cell/gene therapy programs.

5. Takara Bio Inc.

Takara Bio develops plasmid DNA technologies for regenerative medicine, gene therapy, and life science research applications.

6. Lonza Group AG

Lonza provides plasmid DNA manufacturing for gene therapy and vaccine developers, delivering end-to-end CDMO solutions from preclinical to commercial stages.

7. Charles River Laboratories International, Inc.

Charles River offers plasmid DNA production and analytical services, supporting gene therapy, vaccines, and advanced biologics development.

8. Wuxi Advanced Therapies (Wuxi AppTec)

Wuxi Advanced Therapies provides plasmid DNA, viral vector, and cell therapy manufacturing, offering integrated end-to-end solutions for global biopharma.

9. GenScript Biotech Corporation

GenScript offers plasmid DNA synthesis, cloning, and production services, supporting research, diagnostics, vaccines, and therapeutic applications.

10. Touchlight Genetics Ltd.

Touchlight develops enzymatic DNA technology, producing synthetic DNA (doggy bone DNA) and plasmid DNA for gene therapy, vaccines, and genetic medicines.

How big is the Plasmid DNA Market : FAQ's